Sinopharm applies for vaccine market approval
chinadaily.com.cn |
Updated: 2020-11-25 14:29
Share
Share - WeChat
Leading COVID-19 vaccine developer Sinopharm has submitted a market approval application to the top market regulator, according to media reports.
- Memorial ceremony remembers victims of Nanjing Massacre
- Louvre's largest showcase in China goes on display at Museum of Art Pudong in Shanghai
- Indonesian foundation to fund students, school administrators to exchange and study in Tianjin
- Archives detailing crimes of Japanese unit released
- 'Reservoirs of primordial water' may be buried deep within Earth
- China remembers victims of Nanjing Massacre, 88 years on
